Daily Trade

Earlier this year, investors piled into economic reopening and travel stock names. This made sense. The media was playing up the “Roaring 20s” narrative as it was hoped that rapid vaccination rates and a surging economy would lead to a summer of vacations, partying, and pent-up enthusiasm. Ashford Hospitality Trust (NYSE:AHT) stock was one such
0 Comments
Corn futures turned higher Friday, finding support a day after settling at the lowest since January, as USDA lifted its U.S. production forecast, but also raised demand expectations for the commodity. In its monthly World Agricultural Supply and Demand Estimates report, the USDA raised its outlook on 2021/2022 U.S. corn production by 246 million bushels
0 Comments
In a time when the streaming wars are running full-throttle, you might assume that entertainment content provider Eros STX Global (NYSE:ESGC) should be a darling of the markets. Yet, the price performance of ESGC stock hasn’t been stellar this year. Source: Shutterstock.com Just to provide some background, Eros STX Global specializes in delivering “star-driven premium content
0 Comments
The pitcher responsible for the first (and only) no-hitter in the history of the New York Mets is longing for a hit with the sale of his southwest Florida home. The former All-Star Johan Santana commissioned this glorious mansion in Miromar Lakes, FL, in 2009, while he was starring for the Mets. Now, the 9,121-square-foot home on about a half-acre of
0 Comments
On the front-facing side of things, you might not find a better no-brainer (albeit highly speculative) narrative than Zomedica (NYSEAMERICAN:ZOM), the veterinary care specialist focusing on diagnostics platforms. Previously driven by intense meme pressure, ZOM stock found itself providing blistering returns before it all went sour. Source: Postmodern Studio / Shutterstock.com Unlike other meme trades
0 Comments
COVID-19 is not the biggest threat facing humanity. Global warming packs the “greatest threat” to public health, argues an unprecedented joint statement out Tuesday from more than 200 U.S. and international medical journals. The medically-trained editorial staffs of such leading publications as The Lancet and The New England Journal of Medicine and others insist that global leaders must
0 Comments
It was the worst kind of paper jam. A 79-year-old toner salesman was sentenced to four years in prison for running a decades-long, multi-million dollar scam that caused tens of thousands of small businesses and charities to pay hugely inflated prices for printer cartridges. Gilbert Michaels, of West Los Angeles, was accused of utilizing boiler
0 Comments
Belarus Jails One of Its Last Leading Dissidents for 11 Years A Minsk court found Maria Kalesnikava guilty of conspiring to seize power, creating an extremist group, and calling for actions that could damage national security, effectively silencing the last main opposition voice stil… Sep. 6, 2021 at 10:57 a.m. ET by Ann M. Simmons
0 Comments
It’s been a little more than three weeks since Zomedica (NYSEAMERICAN:ZOM) reported its Q2 results. Despite reasonably healthy sales, ZOM stock gained just 14% from Aug. 11 through the end of the month.  Source: Postmodern Studio / Shutterstock.com Another InvestorPlace columnist, Ian Bezek, recently argued that Zomedica needs to raise its revenues considerably before investors
0 Comments